Delirium is a neurological (nervous system) condition and a serious disturbance in mental abilities that causes mental confusion and emotional disruption. Delirium can be caused due to various factors such as older age, exposure to certain medications, alcohol abuse, surgery or other medical procedures, factors such as exposure to toxic or infectious agents, physical trauma, diet, and behavioral and occupational factors.

The global delirium market is majorly driven by the ... Read more

Key Players

Some of the key players in the delirium market are Dr. Franz Kohler Chemie GmbH, Fraser Health, Gaia BioPharma Ltd., Novartis AG, Pfizer, Inc., Regenstrief Institute, Inc., and Air Liquide Sante International, among others.

Regional Analysis

The Americas dominates the global delirium market owing to the increasing aging population and increasing rate of neurological conditions. Additionally, the increasing government ... Read more

Key Players

Some of the key players in the delirium market are Dr. Franz Kohler Chemie GmbH, Fraser Health, Gaia BioPharma Ltd., Novartis AG, Pfizer, Inc., Regenstrief Institute, Inc., and Air Liquide Sante International, among others.

Regional Analysis

The Americas dominates the global delirium market owing to the increasing aging population and increasing rate of neurological conditions. Additionally, the increasing government ... Read more

Delirium Market Research Report: By Type (Hyperactive, Hypoactive, Mixed), Treatment (Antipsychotics, Supportive Care), Diagnosis (Laboratory Tests, Imaging Tests, Physical Examination), End-User (Hospitals, Specialty Centers) – Global Forecast Till 2023

Market Highlights

The Global Delirium Market is expected to grow at a CAGR of 6% during the forecast period. Delirium is a ... Read more